Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed: 20,548
Companies: 1,769
Drugs tracked: 4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources

Quick answer

Anti-CD123 CAR NK cells

Anti-CD19 UCAR-T cells

Anti-CD5 CAR NK cells

Aramchol

Aramchol

Aramchol

Aramchol free acid tablet 600mg, single dose

Aramchol meglumine

BCMA/CD70 CAR-T cells

BCMA/CD70-targetd CAR-T

BGM-2121

BMN 111 administration via Injector Pen

Bioequivalence clinical trial of two formulations of rosuvastatin.

C-4-29 Cells

CAR-T cells

CD19 CAR-T cells

CD19 targeted CAR-T cells

CD19-targetd CAR-T

CD70 CAR-T cells

CD70 CAR-T cells

CD70 CAR-T cells

CD70-targeted CAR-T cells

CEA CAR-T cells

CEA CAR-T cells

Frequently asked questions